Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cefepime”

56 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 56 results

Large-scale testing (Phase 3)Ended earlyNCT01110408
What this trial is testing

A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections

Who this might be right for
Complicated Urinary Tract Infections or Pyelonephritis
Janssen Research & Development, LLC 41
Not applicableStudy completedNCT05535751
What this trial is testing

Cefepime vs. Carbapenems for Treating AmpC β-lactamase-producing Enterobacteriaceae Bloodstream Infections

Who this might be right for
Bacteremia
University Hospital, Strasbourg, France 200
Post-approval studies (Phase 4)Study completedNCT00358202
What this trial is testing

Cefepime vs. Ceftriaxone to Treat Nursing Home-Acquired Pneumonia

Who this might be right for
Pneumonia
CPL Associates 69
Early research (Phase 1)Study completedNCT02532140
What this trial is testing

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WCK 5107 Alone and in Combination With Cefepime

Who this might be right for
Healthy
Wockhardt 88
Early research (Phase 1)Study completedNCT03630094
What this trial is testing

Plasma and Intrapulmonary Concentrations Study of WCK 5222

Who this might be right for
PHA1A
Wockhardt 36
Large-scale testing (Phase 3)Study completedNCT00044759
What this trial is testing

Study Comparing the Safety and Efficacy of Piperacillin/Tazobactam to Cefepime in Patients With Hematologic Malignancy or Lymphoma

Who this might be right for
Hematologic Neoplasms
Wyeth is now a wholly owned subsidiary of Pfizer
Not applicableStudy completedNCT02581280
What this trial is testing

Population Pharmacokinetics of Teicoplanin, Levofloxacin, Piperacillin/Tazobactam, Meropenem, Vancomycin, Remifentanil, Cefepime, Cefpirome, Sufentanil, Midazolam, Clopidogrel, Ticagrelor, Prasugrel During Veno-arterial Extracorporeal Membrane Oxygenation (VA ECMO)

Who this might be right for
Cardiac Dysfunction
Yonsei University 56
Not applicableStudy completedNCT00177931
What this trial is testing

Cefepime Pharmacokinetics in Liver Transplant Recipients in an Intensive Care Unit

Who this might be right for
Evidence of Liver Transplantation
University of Pittsburgh 25
Early research (Phase 1)Study completedNCT01484015
What this trial is testing

Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia

Who this might be right for
Adult Acute Lymphoblastic LeukemiaAdult Acute Myeloid LeukemiaAdult Burkitt Lymphoma+36 more
Wake Forest University Health Sciences 70
Large-scale testing (Phase 3)WithdrawnNCT06168734
What this trial is testing

Cefepime-taniborbactam vs Meropenem in Adults With VABP or Ventilated HABP

Who this might be right for
Ventilator-associated PneumoniaHospital-acquired Pneumonia
Venatorx Pharmaceuticals, Inc.
Early research (Phase 1)Study completedNCT04951505
What this trial is testing

Safety and Intrapulmonary Pharmacokinetics of Cefepime and Taniborbactam in Healthy Subjects

Who this might be right for
Healthy Subjects
Venatorx Pharmaceuticals, Inc. 30
Not applicableStudy completedNCT03790631
What this trial is testing

The OPTIMAL TDM Study: Determining Optimal Beta-lactam Plasma Concentrations Through Therapeutic Drug Monitoring

Who this might be right for
Beta-lactam AntibioticsTherapeutic Drug MonitoringToxicity+8 more
University of Geneva, Switzerland 771
Large-scale testing (Phase 3)Ended earlyNCT01110421
What this trial is testing

A Safety and Tolerability Study of Doripenem Compared With Cefepime in Hospitalized Children With Bacterial Pneumonia

Who this might be right for
Pneumonia, BacterialCommunity-Acquired InfectionsNosocomial Infection+1 more
Janssen Research & Development, LLC 7
Testing effectiveness (Phase 2)Study completedNCT03680612
What this trial is testing

Cefepime/AAI101 Phase 2 Study in Hospitalized Adults With cUTI

Who this might be right for
Urinary Tract Infections
Allecra 45
Testing effectiveness (Phase 2)Study completedNCT03485950
What this trial is testing

Comparative Study To Determine The Efficacy, Safety, And Tolerability Of Ceftolozane-Tazobactam

Who this might be right for
Other Infectious Diseases
M.D. Anderson Cancer Center 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT03078010
What this trial is testing

Choosing the Best Antibiotic to Protect Friendly Gut Bacteria During the Course of Stem Cell Transplant

Who this might be right for
Intestinal MicrobiomeFebrile Neutropenia
Memorial Sloan Kettering Cancer Center 347
Post-approval studies (Phase 4)UnknownNCT04233996
What this trial is testing

Efficacy of Extended Infusion of β-lactam Antibiotics for the Treatment of Febrile Neutropenia in Hematologic Patients

Who this might be right for
Febrile Neutropenia
Hospital Universitari de Bellvitge 150
Early research (Phase 1)Study completedNCT03680352
What this trial is testing

Pharmacokinetics of Cefepime and AAI101 in Subjects With Renal Insufficiency and Healthy Subjects

Who this might be right for
PK in Patients With Various Degrees of Renal Impairment
Allecra 30
Large-scale testing (Phase 3)Study completedNCT00137787
What this trial is testing

Comparing Ciprofloxacin (CPFX) With Cefepime (CFPM) in Febrile Neutropenic Patients With Hematologic Diseases

Who this might be right for
Febrile Neutropenia
Center for Supporting Hematology-Oncology Trials 51
Early research (Phase 1)Study completedNCT02707107
What this trial is testing

MED Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous WCK 5222 (Zidebactam and Cefepime) in Healthy Volunteers

Who this might be right for
Serious Gram-negative Infections
Wockhardt 20
Load More Results